Yervoy (ipilimumab) - BMS
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy (clinicaltrials.gov) - Sep 16, 2026 - P1 | N=20 | Recruiting | Sponsor: M.D. Anderson Cancer Center | Phase classification: P ➔ P1 
Phase classification • Oncology • Solid Tumor • ALK • EGFR
http://clinicaltrials.gov/ct2/show/NCT07655583
 
Sep 16, 2026
 
Prev Next